281683
State alcohol control policies and alcohol-impaired driving in the United States
Methods: An Alcohol Policy Scale (APS) score was created from data on 29 state-level alcohol control policies from the Alcohol Policy Information System and other data sources and weighted by their relative efficacy and degree of implementation for each U.S. state and year from 2002-2010. A scale to measure the alcohol impaired driving environment (AID-APS) was derived by restricting the APS to the 15 policies that were driving-oriented. The relationships among APS and AID-APS scores and state-level prevalence of self-reported AID from the Behavioral Risk Factor Surveillance System surveys from 2002-2010 were examined.
Results: APS scores varied substantially by state and were inversely associated with impaired-driving (r=-0.54, p<0.01, R2=0.30); AID-APS scores also varied by state and were inversely correlated with AID, although the AID-APS explained less variance between states (r=-0.36, p<0.01, R2=0.13) than the overall APS score.
Summary: States with stronger overall alcohol control environment had lower prevalence of less self-reported AID. More work is necessary to better understand the relative effect of policies targeting excessive drinking versus those targeting driving after drinking.
Learning Areas:
Conduct evaluation related to programs, research, and other areas of practicePublic health or related laws, regulations, standards, or guidelines
Public health or related public policy
Public health or related research
Social and behavioral sciences
Learning Objectives:
Describe the relationship between the state-level alcohol policy environment and self-reported alcohol impaired driving (AID).
Keyword(s): Alcohol, Public Health Policy
Qualified on the content I am responsible for because: I am a professor of biostatistics with decades of experience in conducting research on alcohol impaired driving.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.